IGM Biosciences, Inc.

$1.27+0.00%(+$0.00)
TickerSpark Score
74/100
Solid
87
Valuation
50
Profitability
100
Growth
84
Health
50
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IGMS research report →

52-Week Range2% of range
Low $0.92
Current $1.27
High $22.50

Companyigmbio.com

IGM Biosciences, Inc. , a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin's lymphoma (NHL).

CEO
Mary Beth Harler
IPO
2019
Employees
149
HQ
Mountain View, CA, US

Price Chart

-85.44% · this period
$17.83$9.42$1.02Aug 14Feb 14Aug 15

Valuation

Market Cap
$77.50M
P/E
9.70
P/S
0.54
P/B
0.77
EV/EBITDA
1.52
Div Yield
0.00%

Profitability

Gross Margin
98.07%
Op Margin
25.28%
Net Margin
5.57%
ROE
16.11%
ROIC
36.20%

Growth & Income

Revenue
$2.68M · 25.77%
Net Income
$-195,795,000 · 20.54%
EPS
$-3.24 · 31.21%
Op Income
$-208,580,000
FCF YoY
22.37%

Performance & Tape

52W High
$22.50
52W Low
$0.92
50D MA
$1.27
200D MA
$3.58
Beta
0.59
Avg Volume
634.44K

Get TickerSpark's AI analysis on IGMS

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Aug 14, 25BAKER BROS. ADVISORS LPother3,763,362
Aug 14, 25BAKER BROS. ADVISORS LPother9,886,217
Aug 14, 25Redmile Group, LLCsell2,964,843
Aug 14, 25Redmile Group, LLCsell7,199,325
Aug 14, 25Redmile Group, LLCsell667,666
Aug 14, 25Hambleton Juliesell2,000
Aug 14, 25Lee Michael Stewartsell12,712
Aug 14, 25Topsoe Holding A/Ssell5,044,295
Aug 14, 25Topsoe Holding A/Ssell10,400,564
Aug 14, 25Topsoe Jakob Haldorsell5,044,295

Our IGMS Coverage

We haven't published any research on IGMS yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate IGMS Report →

Similar Companies